The division of Cardiology at Raja Super Speciality Clinic is headed by Dr. Deep Chandh Raja S. He is a Senior Consultant Cardiologist who had his 3-year Intervention Cardiology training at the Madras Medical Mission & 3-yr Advanced Cardiac Electrophysiology training at the Canberra Heart Rhythm Center, Canberra Hospitals & Australian National University. Dr. Deep Chandh Raja had completed his ear
ly Cardiology training (DM- Doctor of Medicine) from the renowned Sanjay Gandhi Postgraduate Institute (SGPGI, Lucknow) and Internal Medicine training from the busy King George Medical College and University (KGMC, Lucknow). Dr Deep Chandh Raja is Specialists in
• Heart Rhythm disorders (Arrhythmias, Atrial fibrillation, Ventricular tachycardias)
• Heart Rhythm disorders (Arrhythmias, Atrial fibrillation, Ventricular tachycardias)
• Heart failure management
• Cardiac resynchronization device implants & management
• Heart attack prevention and management
• Coronary stent interventions & management
Dr Deep Chandh Raja has participated in multiple international & national clinical trials.
• Novel risk stratification tools in Non-Ischemic Cardiomyopathy
• Co-investigator: BIOMASTER.BIOMONITOR III, 2020 – till date – A multi-centre, international, open label study. The aim of the study is to test the safety and efficacy of the FIT OneStep which will be used as an insertion tool to implant the BIOMONITOR III.
• Co-investigator: OCEAN, Optimal antiCoagulation for Enhanced risk pAtients Post-catheter ablatioN for atrial fibrillation, 2019 – till date – OCEAN is a prospective, open label, randomised controlled study aimed to investigate the superiority of long-term oral anticoagulation over antiplatelet therapy in preventing stroke in AF patients after their catheter ablation. The study is sponsored by Ottawa Heart Institute Research Corporation based in Ottawa, Canada.
• Co-investigator: CAPLA, Catheter Ablation for Persistent atriaL fibrillAtion, 2019 – till date. It assesses the effect of posterior left atrial wall isolation (PWI) with PVI (Pulmonary vein isolation) method in comparison to PVI method alone in atrial fibrillation ablation recurrence rate.
• Co-investigator: SOLVE CRT, Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronisation Therapy, 2019 – till date – Solve-CRT is a multi-centre, randomized and double-blind trial. The patients have cardiac indications of either in Class I, Class IIa and Class IIb, in which their CRT have either failed to respond or have been unable to receive conventional CRT. The aim of the study is to test a new method to place the CRT. The study is funded by EBR Systems from United States of America.
• Coinvestigator studies at the MMM: Pilot study iFR vs FFR, MASTER-DAPT trial
Academic achievements & Awards
• Best case for fellows at Transcatheter-Cardiovascular Therapeutics (TCT) 2017, Denver, USA
• AV Gandhi award (2017) for excellence in cardiology
• Best original article (Dr. JC Patel and BC Mehta award, 2017) by the Association of Physicians of India JAPI, India
• Best case at the annual Indian Heart Rhythm Society conference (2017)
• Prize finalist (Heart Rhythm oral and poster) at CSANZ 2019, Adelaide
• Best Case series at Annual Electrophysiology conference, IHRS 2017, Ahmedabad, India
• Won Best Paper presentation award at national CSICON in 2016
• Won Best Poster presentation award at national APICON in 2012
• Won Academic Award for First rank in University examinations in Physiology in MBBS
• Distinctions in Anatomy, Physiology, Pharmacology in MBBS
